Applied In Vitro Toxicology
Applied In Vitro Toxicology is a peer-reviewed journal providing the latest research on the development, validation and application of new and innovative in vitro testing methods for predicting adverse effects of drugs, chemicals, and products in the pharmaceutical, chemical, or personal care industries. The Journal addresses in depth the issues facing these industries, by including discussions on regulatory requirements; the reduction, refinement, and replacement of animal testing; new screening methods; evaluation of new cell and tissue models; and the most appropriate methods for assessing safety and satisfying regulatory demands.
Applied In Vitro Toxicology endeavors to serve as the foremost journal for researchers focusing on the development and use of in vitro methods to understand the effects of test agents on biological systems. Organizations involved with hazard identification and risk assessment will want to read AIVT in order to understand how new and existing in vitro methods are applied, and the questions for which these models provide answers.
Applied In Vitro Toxicology coverage includes:
Applied in vitro toxicology industry standards
New technologies developed for applied in vitro toxicology
Data acquisition, cleaning, distribution, and best practices
Data protection, privacy, and policy
Business interests from research to product
The changing role of in vitro toxicology
Visualization and design principles of applied in vitro toxicology infrastructures
Physical interfaces and robotics
Opportunities around applied in vitro toxicology
Applied In Vitro Toxicology is under the editorial leadership of Editor-in-Chief Andrew Gow, PhD, DABT, Rutgers University, and Deputy Editor Chantra Eskes, PhD, SeCAM, and other leading researchers.
Audience: Research and developmental scientists; pharmaceutical, veterinary, horticultural, and chemical researchers; toxicologists, product manufacturers, regulators, among others
Submit Your Research
We strongly encourage academic laboratories to submit their work on new methods or using in vitro models to address issues related to cellular or molecular biology. Computational toxicologists are also encouraged to submit their novel modelling and other data to the journal. The Journal actively delivers the latest views and opinions of researchers developing new models, end users of the models, academic laboratories inventing new tools, and regulatory agencies in the United States, Europe, Latin America, Australia, and Asia.
| Daniel Acosta Jr, PhD | University of Texas at Austin, Austin, TX, USA |
| Shaheda Ahmed, BSC, PhD | Newcastle University, Newcastle upon Tyne, UK |
| Timothy E H Allen, PhD | University Of Cambridge, Lensfield Road, UK |
| Anthony Bahinski, PhD, MBA | GlaxoSmithKline, King of Prussia, PA, USA |
| Kenneth R. Brouwer, PhD, RPH | Chapel Hill, NC, USA |
| Francois Busquet, PhD | Caat Eu Policy, Bruxelles, Belgium |
| Paul L. Carmichael, BSC, PhD | Harrold Bedford, United Kingdom |
| Harvey J. Clewell Iii, PhD | Hamner Institutes For Health Sciences, Research Triangle Park, NC, USA |
| Amy J. Clippinger, PhD | Peta Science Consortium Intl E.V, Norfolk, VA, USA |
| Kelly P. Coleman, PhD, DABT | Medtronic Physiological Resrch Labs, Minneapolis, MN, USA |
| Samuel Constant, PhD | Epithelix Sarl, Geneva, Switzerland |
| Julio C. Davila, PhD | Vero Beach, FL, USA |
| Bertrand Desprez | Cosmetics Europe - The Personal Care Association, Brussels, Belgium |
| Robert T. Dunn, II, PhD | Charles River Laboratories, Shrewsbury, MA, USA |
| Chantra Eskes, PhD | European Food Safety Authority, Parma, Italy |
| Gemma Falco Alay | Reach Monitor, Barcelona, Spain |
| Stephens Ferguson | Natnl Inst Of Environmental Hlth Scnces, Research Triangle Park, NC, USA |
| Marianna D. Gaca, PhD | British American Tobacco, Southampton Hants, United Kingdom |
| Andrew Gow, PhD | Rutgers University, Piscataway, NJ, USA |
| Claudius Griesinger, PhD, MSC | Ispra, Lombardy, Italy |
| Patrina Gunness, PhD | Oshawa, ON, Canada |
| Thomas Hartung, MD, PhD | Johns Hopkins University, Baltimore, MD, USA |
| Patrick J. Hayden | Mattek Corp, Ashland, MA, USA |
| Jonathan Jackson, PhD, DABT | Pfizer World Wide Research & Development, Groton, CT, USA |
| Nicole C. Kleinstreuer, PhD | Ls/National Toxicology Program, Research Triangle Park, NC, USA |
| Hajime Kojima, PhD | National Inst Of Health Sciences (Nihs), Tokyo, Japan |
| Nynke I. Kramer, PhD | Wageningen University, Wageningen, Netherlands |
| Takatoshi Kuhara, DVM, PhD | Juntendo University School of Medicine, Tokyo, Japan |
| Seung Jun Kwack, PhD | Changwon National University, Gyeongnam, South Korea |
| Edward L. Lecluyse, PhD | Hamner Institutes For Health Sciences, Research Triangle Park, NC, USA |
| Brett A. Lidbury, PhD, FFSC, (RCPA) | |
| Wang Liping | Nanjing Agricultural University, Nanjing, China |
| Yitong Liu, PhD | Us Food & Drug Administration, Laurel, MD, USA |
| James M. Mckim, PhD, DABT | Iontox Llc, Kalamazoo, MI, USA |
| Vanessa De Moura Sa Rocha | Natura Inovacao, Polvilho Cajamar, Brazil |
| Reine R. Note | |
| Hilmi Orhan | Ege University, Izmir, Turkey |
| Amy L. Roe, PhD, DABT | Procter & Gamble Company, Mason, OH, USA |
| Erwin L. Roggen, PhD | 3Rs Management And Consulting Aps, Lyngby, Denmark |
| Gilbert Schonfelder | Federal Institute For Risk Assessment, Berlin, Germany |
| Viny Srinivasan, PhD, DABT, ERT | Loreal R&I - Americas Region, Clark, NJ, USA |
| Mathieu Vinken, PHARMD | Vrije Univers Brussel/Free Univ Brussels, Brussels, Belgium |
| Kendall B. Wallace, PhD, DABT | University Of Minnesota, Duluth, MN, USA |
| Dirk Weisensee, PhD | Xenios Ag A Fresensius Med Care Company, Heilbronn, Germany |
| Larry C. Wienkers, PhD | Amgen, Seattle, WA, USA |
| Melissa Wilkinson, PhD | The Defense Threat Reduction Agency, Arlington, VA, USA |
| Yvonne Will, PhD | Scientia Consultants Llc, Encinitas, CA, USA |
| Jamin A. Willoughby, PhD | Iontox Llc, Kalamazoo, MI, USA |
| Jeremy Wong | Estee Lauder Companies Inc, Melville, NY, USA |
| Uri Wormser | Hebrew University, Jerusalem, Israel |